Great news for the Duchenne Community
EMA recommends approval of first ever treatment for all DMD patients Today The European Medicines Agency (EMA) has recommended the approval of Vamorolone, the first ever treatment for all patients with Duchenne muscular dystrophy (DMD). Vamorolone is an alternative to corticosteroids, which are recommended for use in the treatment of DMD as they can help […]